Oral therapeutic administration of a probiotic mixture suppresses established Th2 responses and systemic anaphylaxis in a murine model of food allergy

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 66, Issue 4, 2011, Pages 499-508

  Schiavi, E ^a   Barletta, B ^a   Butteroni, C ^a   Corinti, S ^a   Boirivant, M ^a   Di Felice, Gabriella ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Anaphylaxis; Animal models; Basic mechanisms; Food allergy

Indexed keywords

GAMMA INTERFERON; HISTAMINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 27; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; PROBIOTIC AGENT; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TROPOMYOSIN; VSL3;

ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FECES; FEMALE; FOOD ALLERGY; HISTAMINE RELEASE; JEJUNUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SCORING SYSTEM; SENSITIZATION; SPLEEN CELL; TH1 CELL; TH2 CELL;

ADMINISTRATION, ORAL; ANAPHYLAXIS; ANIMALS; CELL SEPARATION; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; FOOD HYPERSENSITIVITY; MICE; POLYMERASE CHAIN REACTION; PROBIOTICS; TH2 CELLS;

EID: 79952029466     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2010.02501.x     Document Type: Article

References (43)

1. Akdis CA, Akdis M. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J Allergy Clin Immunol 2009;123:735-746.
2. Chehade M, Mayer L. Oral tolerance and its relation to food hypersensitivities. J Allergy Clin Immunol 2005;115:3-12.
3. Iweala OI, Nagler CR. Immune privilege in the gut: the establishment and maintenance of non-responsiveness to dietary antigens and commensal flora. Immunol Rev 2006; 213:82-100. (Pubitemid 44401495)
4. Mills EN, Breiteneder H. Food allergy and its relevance to industrial food proteins. Biotechnol Adv 2005;23:409-414. (Pubitemid 40984977)
5. Von Mutius E. The raising trends in asthma and allergic disease. Clin Exp Allergy 1998; 28:45-49.
6. Sicherer SH, Sampson HA. Food allergy. J Allergy Clin Immunol 2010;125:S116-S125.
7. Reese G, Ayuso R, Lerher SB. Tropomyosin: an invertebrate panallergen. Int Arch Allergy Immunol 1999;119: 247-258.
8. Daul CB, Slattery M, Reese G, Lehrer SB. Identification of the major brown shrimp (Penaeus aztecus) allergen as the muscle protein tropomyosin. Int Arch Allergy Immunol 1994;105:49-55. (Pubitemid 24281001)
9. Ayuso R, Lehrer SB, Reese G. Identification of continuous, allergenic regions of the major shrimp allergen Pen a 1 (tropomyosin). Int Arch Allergy Immunol 2002;127: 27-37. (Pubitemid 34224950)
10. Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001;108:516-520. (Pubitemid 32978019)
11. Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001;107:129-134. (Pubitemid 32105256)
12. Rautava S, Kalliomaki M, Isolauri E. New therapeutic strategy for combating the increasing burden of allergic disease: probiotics. A Nutrition, Allergy, Mucosal Immunology and Intestinal Microbiota (NAMI) Research Group report. J Allergy Clin Immunol 2005;116:31-37. (Pubitemid 40909743)
13. Savilahti E, Kuitunen M, Vaarala O. Pre and probiotics in the prevention and treatment of food allergy. Curr Opin Allergy Clin Immunol 2008;8:243-248.
14. Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food. Guidelines for the Evaluation of Probiotics in Food (2002), WHO, Geneva.
15. Lee J, Seto D, Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol 2008;121:116-121.
16. Michail SK, Stolfi A, Johnson T, Onady GM. Efficacy of probiotics in the treatment of pediatric atopic dermatitis: a metaanalysis of randomized controlled trials. Ann Allergy Asthma Immunol 2008;101: 508-516.
17. Vliagoftis H, Kouranos VD, Betsi GI, Falagas ME. Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials. Ann Allergy Asthma Immunol 2008;101:570-579.
18. Boyle RJ, Bath-Hextall FJ, Leonardi-Bee J, Murrell DF, Tang ML-K. Probiotics for the treatment of eczema: a systematic review. Clin Exp Allergy 2009;39:1117-1127.
19. Di Giacinto C, Marinaro MM, Sanchez M, Strober W, Boirivant M. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-β-bearing regulatory cells. J Immunol 2005; 174:3237-3246. (Pubitemid 40354026)
20. Chapman TM, Plosker GL, Figgitt DP. VSL#3 Probiotic mixture. A review of its use in chronic inflammatory bowel diseases. Drugs 2006;66:1371-1387.
21. Camilleri M. Probiotics and irritable bowel syndrome: rationale, putative mechanisms, and evidence of clinical efficacy. J Clin Gastroenterol 2006;40:264-269. (Pubitemid 44309565)
22. Gionchetti P, Rizzello F, Morselli C, Poggioli G et al. High-dose probiotics for the treatment of active pouchitis. Dis Colon Rectum 2007;50:2075-2084.
23. Pronio A, Montesani C, Butteroni C, Vecchione S et al. Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells. Inflamm Bowel Dis 2008;14:662-668. (Pubitemid 351742983)
24. Bowen JM, Stringer AM, Gibson RJ, Yeoh ASJ, Hannam S, Keefe DMK. VSL#3 Probiotic treatment reduces chemotherapyinduced diarrhoea and weight loss. Cancer Biol Ther 2007;6:1449-1454. (Pubitemid 351590357)
25. Calcinaro F, Dionisi S, Marinaro MM, Candeloro P et al. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 2005;48:1565-1575. (Pubitemid 41175510)
26. Mastrangeli G, Corinti S, Butteroni C, Afferni C et al. Effects of live and inactivated VSL#3 probiotic preparations in the modulation of in vitro and in vivo allergeninduced Th2 responses. Int Arch Allergy Immunol 2009;150:133-143.
27. Capobianco F, Butteroni C, Barletta B, Corinti S et al. Oral sensitisation with Shrimp Tropomyosin induces in mice allergen-specific IgE, T cell response and systemic anaphylactic reactions. Int Immunol 2008; 20:1077-1086.
28. Morafo V, Srivastava K, Huan C-K, Kleiner G et al. Genetic susceptibility to food allergy is linked to differential TH2-TH1 responses in C3H/HeJ and BALB/c mice. J Allergy Clin Immunol 2003;111:1122-1128. (Pubitemid 36570876)
29. Reese G, Schicktanz S, Lauer I, Randow S et al. Structural, immunological and functional properties of natural recombinant Pen a 1, the major allergen of Brown Shrimp, Penaeus aztecus. Clin Exp Allergy 2006;36:517-524.
30. Li X-M, Schofield BH, Huang C-K, Kleiner GI, Sampson HA. A murine model of IgE-mediated cow's milk hypersensitivity. J Allergy Clin Immunol 1999;103:206-214. (Pubitemid 29095823)
31. Adel-Patient K, Bernard H, Ah-Leung S, Creminon C, Wal J-M. Peanut- and cow's milk-specific IgE, Th2 cells and local anaphylactic reaction are induced in Balb/c mice orally sensitized with cholera toxin. Allergy 2005;60:658-664.
32. Boirivant M, Pallone F, Di Giacinto C, Fina D et al. Inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-beta1-mediated suppression of colitis. Gastroenterology 2006;131:1786-1798. (Pubitemid 44958514)
33. Shida K, Takahashi R, Iwadate E, Takamizawa K et al. Lactobacillus casei Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model. Clin Exp Allergy 2002;32:563-570. (Pubitemid 34429576)
34. Kim H, Kwack K, Kim DY, Ji GE. Oral probiotic bacterial administration suppressed allergic responses in an ovalbumin-induced allergy mouse model. FEMS Immunol Med Microbiol 2005;45:259-267. (Pubitemid 41040010)
35. Frossard CP, Steidler L, Eigenmann PA. Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitisation. J Allergy Clin Immunol 2007;119:952-959. (Pubitemid 46527811)
36. Kim JY, Choi YO, Ji GE. Effect of oral probiotics (Bifidobacterium lactis AD011 and Lactobacillus acidophilus AD031) administration on ovalbumin-induced food allergy mouse model. J Microbiol Biotechnol 2008;18:1393-1400.
37. Trinchieri G, Pflanz S, Kastelein RA. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 2003;19:641-644. (Pubitemid 37490789)
38. Stumhofer SJ, Hunter CA. Advances in understanding the anti-inflammatory properties of IL-27. Immunol Lett 2008;117:123-130.
39. Yoshida H, Nakaya M, Miyazaki Y. Interleukin 27: a double-edged sword for offence and defense. J Leukoc Biol 2009;86:1295-1303.
40. Goriely S, Neurath MF, Goldman M. How microorganisms tip the balance between interleukin-12 family members. Nat Rev Immunol 2008;8:81-86.
41. Wirtz S, Becker C, Fantini MC, Nieuwenhuis EE et al. EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kB activation. J Immunol 2005;174:2814-2824. (Pubitemid 40279698)
42. Tanabe S, Kinuta Y, Saito Y. Bifidobacterium infantis suppresses proinflammatory interleukin-17 production in murine splenocytes and dextran sodium sulfate-induced intestinal inflammation. Int J Mol Med 2008;22:181-185.
43. Rutz S, Janke M, Kassner N, Hohnstein T, Krueger M, Scheffold A. Notch regulates IL-10 production by T helper 1 cells. Proc Natl Acad Sci USA 2008;105:3497-3502. (Pubitemid 351723581)